I. Tugal-Tutkun, "AIN457, A FULLY HUMAN MONOCLONAL ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, FOR THE ADJUNCTIVE TREATMENT OF POSTERIOR SEGMENT UVEITIS SECONDARY TO BEHCET'S DISEASE: THE SHIELD STUDY," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010
Tugal-Tutkun, I. 2010. AIN457, A FULLY HUMAN MONOCLONAL ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, FOR THE ADJUNCTIVE TREATMENT OF POSTERIOR SEGMENT UVEITIS SECONDARY TO BEHCET'S DISEASE: THE SHIELD STUDY. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4 .
Tugal-Tutkun, I., (2010). AIN457, A FULLY HUMAN MONOCLONAL ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, FOR THE ADJUNCTIVE TREATMENT OF POSTERIOR SEGMENT UVEITIS SECONDARY TO BEHCET'S DISEASE: THE SHIELD STUDY. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4.
Tugal-Tutkun, Nuriye. "AIN457, A FULLY HUMAN MONOCLONAL ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, FOR THE ADJUNCTIVE TREATMENT OF POSTERIOR SEGMENT UVEITIS SECONDARY TO BEHCET'S DISEASE: THE SHIELD STUDY," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010
Tugal-Tutkun, Nuriye İ. . "AIN457, A FULLY HUMAN MONOCLONAL ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, FOR THE ADJUNCTIVE TREATMENT OF POSTERIOR SEGMENT UVEITIS SECONDARY TO BEHCET'S DISEASE: THE SHIELD STUDY." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010
Tugal-Tutkun, I. (2010) . "AIN457, A FULLY HUMAN MONOCLONAL ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, FOR THE ADJUNCTIVE TREATMENT OF POSTERIOR SEGMENT UVEITIS SECONDARY TO BEHCET'S DISEASE: THE SHIELD STUDY." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4.
@article{article, author={Nuriye İlknur TUTKUN}, title={AIN457, A FULLY HUMAN MONOCLONAL ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, FOR THE ADJUNCTIVE TREATMENT OF POSTERIOR SEGMENT UVEITIS SECONDARY TO BEHCET'S DISEASE: THE SHIELD STUDY}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2010}